Fox Run Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Fox Run Management’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-15,826	Closed	-$808K	–	1295
2024 Q4	$808K	Buy	15,826 +7,830	+98%	+$385K	0.15%	237
2024 Q3	$330K	Buy	7,996 +3,110	+64%	+$149K	0.07%	507
2024 Q2	$235K	Buy	+4,886	New	+$217K	0.04%	619
2023 Q3	–	Sell	-3,885	Closed	-$226K	–	1046
2023 Q2	$226K	Sell	3,885 -2,436	-39%	-$154K	0.06%	542
2023 Q1	$390K	Sell	6,321 -6,130	-49%	-$368K	0.13%	308
2022 Q4	$791K	Buy	+12,451	New	+$903K	0.32%	51

Other funds holding NARI

SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TCWM

Total Clarity Wealth Management St. Charles, Illinois $426M AUM 23.62% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Fox Run Management's NARI Position: Q1 2025 in Review

Fox Run Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 15,826 shares — an estimated $808K sold.

Fox Run Management first reported a position in NARI in Q4 2022 and held it in 6 quarters. The position peaked at $808K in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

Fox Run Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Fox Run Management sold 15,826 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $808K.
Fox Run Management first reported a position in Inari Medical, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
Fox Run Management's Inari Medical, Inc. Common Stock position peaked at $808K in Q4 2024.
4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Fox Run Management's 13F filing for Q1 2025, filed 13 May 2025.